CD70 and glioblastoma: The involvement of CD70 in the generation and/or maintenance of a CSC phenotype has been described in breast cancer, glioblastoma, melanoma, pancreatic carcinoma and non-small cell lung cancer (NSCLC) and thus could serve as a potential marker of stem cells [12, 94].